Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Active Biotech and Avidex collaboration to create potent anticancer agents

May 17, 2004

Novogen commences phase Ia trial with anticancer drug NV-18

May 17, 2004

Millennium begins phase II trial of Velcade-rituximab combination therapy

May 17, 2004

Antitumor effects of second-generation immunomodulatory oligonucleotides

May 17, 2004

New low molecular weight compounds with anticancer and antibacterial activity

May 14, 2004

Sonus completes private placement

May 14, 2004

Novel inhibitors of CDK2 and other kinases under study at Schering-Plough

May 14, 2004

U. of Leiden researchers identify novel inhibitors of GST P1-1

May 14, 2004

Further data on antitumor activity of PEP-005 supporting use as topical anti-skin cancer agent

May 14, 2004

Abraxane NDA accepted for filing

May 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...